MORGAN STANLEY - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 113 filers reported holding ALDEYRA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,664,088
-38.2%
249,115
-22.4%
0.00%
Q2 2023$2,693,426
-77.0%
321,028
-72.8%
0.00%
-100.0%
Q1 2023$11,717,032
+434.0%
1,179,963
+274.3%
0.00%
Q4 2022$2,194,139
+35.8%
315,250
+4.2%
0.00%
Q3 2022$1,616,000
+11.1%
302,643
-17.1%
0.00%
Q2 2022$1,455,000
-7.3%
364,960
+3.3%
0.00%
Q1 2022$1,570,000
+126.6%
353,150
+103.9%
0.00%
Q4 2021$693,000
+43.5%
173,204
+214.2%
0.00%
Q3 2021$483,000
-53.6%
55,120
-39.9%
0.00%
Q2 2021$1,040,000
+436.1%
91,747
+460.3%
0.00%
Q1 2021$194,000
+123.0%
16,375
+29.0%
0.00%
Q4 2020$87,000
+117.5%
12,695
+135.1%
0.00%
Q3 2020$40,000
-95.6%
5,400
-97.5%
0.00%
Q2 2020$908,000
+22600.0%
217,766
+11440.3%
0.00%
Q1 2020$4,000
-97.9%
1,887
-94.3%
0.00%
Q4 2019$191,000
+282.0%
32,876
+250.4%
0.00%
Q3 2019$50,000
+257.1%
9,383
+313.5%
0.00%
Q2 2019$14,000
-73.6%
2,269
-61.1%
0.00%
Q1 2019$53,000
-81.0%
5,839
-82.6%
0.00%
Q4 2018$279,000
-44.2%
33,617
-7.2%
0.00%
Q3 2018$500,000
+47.1%
36,226
-15.3%
0.00%
Q2 2018$340,000
+206.3%
42,772
+189.1%
0.00%
Q1 2018$111,000
+60.9%
14,796
+46.4%
0.00%
Q4 2017$69,000
-2.8%
10,110
+3.3%
0.00%
Q3 2017$71,000
+446.2%
9,783
+249.9%
0.00%
Q2 2017$13,000
-53.6%
2,796
-49.9%
0.00%
Q1 2017$28,000
-12.5%
5,586
-6.3%
0.00%
Q4 2016$32,000
-8.6%
5,964
+33.7%
0.00%
Q3 2016$35,000
+59.1%
4,460
+14.7%
0.00%
Q2 2016$22,000
+46.7%
3,887
+8.3%
0.00%
Q1 2016$15,000
-69.4%
3,589
-50.3%
0.00%
Q4 2015$49,000
-58.8%
7,222
-64.8%
0.00%
Q3 2015$119,000
-7.0%
20,496
+24.2%
0.00%
Q2 2015$128,000
-9.2%
16,504
+19.2%
0.00%
Q1 2015$141,000
+1466.7%
13,841
+964.7%
0.00%
Q4 2014$9,0001,300
+14344.4%
0.00%
Q2 2014$090.00%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Prosight Management, LP 473,446$5,625,0004.61%
Knoll Capital Management, LLC 569,405$6,765,0004.41%
SILVERARC CAPITAL MANAGEMENT, LLC 321,879$3,824,0002.09%
First Light Asset Management, LLC 2,624,001$31,173,0002.07%
Mesirow Financial Investment Management, Inc. 63,634$756,0002.06%
Ghost Tree Capital, LLC 650,000$7,722,0001.82%
Altium Capital Management LP 548,225$6,513,0001.81%
Perceptive Advisors 8,703,879$103,402,0001.31%
Affinity Asset Advisors, LLC 300,000$3,564,0001.21%
Avidity Partners Management LP 2,552,000$30,318,0000.84%
View complete list of ALDEYRA THERAPEUTICS INC shareholders